Results 71 to 80 of about 27,626 (220)

Voriconazole-Associated Phototoxicity

open access: yesDermatology Online Journal, 2011
Voriconazole is an extended-spectrum triazole antifungal approved for treatment of invasive fungal infections. The drug has been associated with phototoxicity, presenting as photodistributed eruptions such as macular erythema or pseudoporphyria. We describe a 59-year-old man with acute myeloid leukemia, status-post matched unrelated donor stem cell ...
Riahi, Ryan R, Cohen, Philip R
openaire   +4 more sources

Clinical and pathological features of two cases of erythematous‐ceruminous otitis externa associated with Candida spp. infection in dogs

open access: yesVeterinary Record Case Reports, Volume 13, Issue 2, June 2025.
Abstract Erythematous‐ceruminous otitis externa is a common presentation of otitis externa in dogs and is usually associated with Malassezia or bacterial overgrowth. This report aims to describe two cases of unilateral erythematous‐ceruminous otitis externa associated with Candida spp. infection. A 2‐year‐old goldendoodle (Case 1) and a 4‐year‐old Jack
Nuria García   +3 more
wiley   +1 more source

A suspected case of autoinduction of voriconazole metabolism in a patient with cerebral aspergillosis

open access: yesDrug, Healthcare and Patient Safety, 2017
Martin J Ferguson,1 Maria L Randles,2 Declan G de Freitas3 1Pharmacy Department, Beaumont Hospital, Beaumont, Dublin, 2Pharmacy Department, Wexford General Hospital, Wexford, 3Department of Transplantation, Urology and Nephrology, Beaumont Hospital ...
Ferguson MJ, Randles ML, de Freitas DG
doaj  

Characterization of COVID‐19‐Associated Candidemia Among Burn Patients

open access: yesJournal of Clinical Laboratory Analysis, Volume 39, Issue 10, May 2025.
This study investigates the distribution of Candida species isolated from burn patients with candidemia, colonization, and urinary cultures. The findings highlight the predominance of C. albicans and C. parapsilosis across different sample types, including wound colonization, blood, and urine.
Maryam Salimi   +12 more
wiley   +1 more source

Enhancing voriconazole therapy in liver dysfunction: exploring administration schemes and predictive factors for trough concentration and efficacy

open access: yesFrontiers in Pharmacology
Introduction: The application of voriconazole in patients with liver dysfunction lacks pharmacokinetic data. In previous study, we proposed to develop voriconazole dosing regimens for these patients according to their total bilirubin, but the regimens ...
Yichang Zhao   +18 more
doaj   +1 more source

Hyperlipidemia Caused by Voriconazole: A Case Report

open access: yesInfection and Drug Resistance, 2021
Jiasheng Wu,1,2,* Na Chen,3,* Yake Yao,1 Jianying Zhou,1 Hua Zhou1 1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, People’s Republic of China;
Wu J, Chen N, Yao Y, Zhou J, Zhou H
doaj  

Voriconazole is a safe and effective anti-fungal prophylactic agent during induction therapy of acute myeloid leukemia

open access: yesIndian Journal of Medical and Paediatric Oncology, 2016
Background: Antifungal prophylaxis (AFP) reduces the incidence of invasive fungal infections (IFIs) during induction therapy of acute myeloid leukemia (AML). Posaconazole is considered the standard of care.
Akash Shah   +8 more
doaj   +1 more source

Therapeutic drug monitoring and safety of voriconazole therapy in patients with Child–Pugh class B and C cirrhosis: A multicenter study

open access: yesInternational Journal of Infectious Diseases, 2018
Objectives: The purpose of this study was to investigate the pharmacokinetic profile and safety of voriconazole treatment in patients with Child–Pugh class B and C cirrhosis. Methods: Liver cirrhosis patients who had received the recommended voriconazole
Taotao Wang   +8 more
doaj  

Home - About - Disclaimer - Privacy